NCT00741871
- Conditions
- B Cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +12 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Lymphoma, Malignant
Explore clinical trials studying Lymphoma, Malignant. Study availability and eligibility vary by location and protocol.
13 public trials
1 recruiting study
Lymphoma, Malignant trial results
NCT00037791
- Conditions
- Blood Platelet Disorders, Blood Protein Disorders, Cardiovascular Diseases, +18 more
- Locations
-
- Pfizer Investigational Site Berkeley, California, United States
- Pfizer Investigational Site La Jolla, California, United States
- Pfizer Investigational Site Los Angeles, California, United States
- Pfizer Investigational Site Los Angeles, California, United States
Active, Not Recruiting
DS-3201b in Participants With Lymphomas
NCT02732275
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
- Locations
-
- City of Hope National Medical center Duarte, California, United States
- Yale University New Haven, Connecticut, United States
- Emory University Atlanta, Georgia, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States